Savvion and Patni to bring BPM to drug development

By Staff Reporter

- Last updated on GMT

Related tags: Pharmacology, Clinical trial

US companies Savvion and Patni Life Sciences hope their new alliance help pharmas biotechs and CROs meet regulatory challenges “across the drug development cycle.”

The increasingly complex rules that govern the global drug industry can be a major headache for drugmakers, with minor region to region variations often lengthening the time its takes to bring a drug to market.

Such delays can “cost” pharmaceutical and biotechnology firms millions in lost revenue which, given the competitive nature of the sector, can have a dramatic impact on performance.

Savvion and Patni, which specialize business process management (BPM) and trial regulatory and IT solutions, respectively, said the collaboration will help address these difficulties by “streamlining [clients’] drug development and clinical trial operations… while leveraging their existing information technology infrastructure​.”

The combined offering will provide Patni's drug industry clients with access to Savvion's range of "BPM-enabled" modelling and optimisation solutions which, the firms claim, will improve the efficiency of clinical development operations.

Roy Devine, VP of consulting services at Patni, said that: “Drug trial managers face tremendous challenges,”​ explaining that “they must deal with expiring drug patents, dwindling drug pipelines, escalating costs of clinical trials, and increasingly stringent new regulatory guidelines that delay time to market.

“This new partnership will enhance Patni’s consulting practice by allowing us to offer Savvion’s pioneering BPM technology along with Patni’s regulatory and IT expertise to help our clients remain competitive.”

Pejman Makhfi, VP of solutions at Savvion also stressed the benefits of the partnership.

Patni’s domain expertise in life sciences and Savvion’s track record for automating complex business processes, we can work together to give the drug industry BPM-enabled solutions to easily meet complex and ever-changing regulatory requirements and shorten the time to market for new drugs​.”

Related news

Related products

show more

Covance Touchless Drug and Device Vigilance Vision

Covance Touchless Drug and Device Vigilance Vision

Covance Patient Safety | 01-Sep-2020 | Data Sheet

Automation tools enable organizations to identify patterns in structured and unstructured data and facilitate automation of the entire product vigilance...

Related suppliers

Follow us

Products

View more

Webinars